medtechdive18h
The PFA race is heating up. Here’s where the market stands after J&J’s approval.
Competition in the fast-growing pulsed field ablation (PFA) market has intensified with the arrival of Johnson & Johnson’s ...
medtechdive18h
FDA warns providers on Getinge devices tied to 17 serious injuries
Physicians use Hemopro 1, which is only marketed outside the U.S., and Hemopro 1.5 to create a new path for blood flow in the ...
medtechdive3d
Boston Scientific closes $3.7B Axonics deal after lengthy review
Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission ...
medtechdive4d
FDA breakthrough device decisions rebound after recent declines
The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...
medtechdive4d
Haemonetics to close California facility, lay off 75 people
Over the past year, Haemonetics has reshaped its product portfolio through restructuring and M&A, adding devices used in ...
medtechdive4d
GE Healthcare’s head-only MRI scanner cleared by the FDA
The system is designed to shorten scan times, which may be better for people who struggle to stay still or have ...
medtechdive4d
Arsenal Medical Launches EMBO-02 Study for NeoCast™ to Assess Treatment of Chronic Subdural Hematoma
Arsenal Medical, a clinical-stage company developing medical devices from innovative biomaterials, today announced the initiation of the EMBO-02 clinical study of NeoCast™ to treat chronic subdural ...